Amber Therapeutics
Amber Therapeutics is a biotechnology company focused on developing innovative therapies for metabolic and cardiovascular diseases. Leveraging cutting‑edge gene editing and RNA‑based platforms, Amber aims to create precision medicines that address the underlying causes of disease. The company collaborates with academic institutions and industry partners to advance its pipeline from preclinical research through clinical trials, with a commitment to safety, efficacy, and patient‑centric outcomes. Amber Therapeutics is backed by leading venture investors and operates from its headquarters in Austin, Texas, serving a global research community.
Amber Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Editing, RNA Therapeutics, and Metabolic Diseases.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Amber Therapeutics API
Public website provides no developer documentation or API specifications.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API
Other 2
Properties that don't map to a standard resource type
Source (apis.yml)
Amber Therapeutics API — frequently asked questions
Does Amber Therapeutics have an API?
Yes. APIs.io lists 1 API from Amber Therapeutics, including Amber Therapeutics API.
Is the Amber Therapeutics API ready for AI agents?
Amber Therapeutics has a Kin Score of 4.0 out of 100 (minimal) and an Agent Readiness score of 6.0 (agent-aware), scored by API Evangelist on 2026-10-31.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.